Giorgio Dini - Concepedia

Author

Giorgio Dini

Istituto Giannina Gaslini

Also Known As

Barbara Bruno, Dini, G, Dini, Giorgio, G DINI, G Dini, G. Dini, GIORGIO DINI, Giorgio Dini, T Demirer

234

Publications

9.9K

Citations

H-Index

Concepts

All Affiliations

Istituto Giannina Gaslini Istituti di Ricovero e Cura a Carattere Scientifico University of Padua Policlinico San Matteo Fondazione University of Bologna

About

Giorgio Dini is an author at Istituto Giannina Gaslini specializing in medicine, transplantation, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	50	5.8K
2	Health Sciences	8	8	524
3	Nursing	1	1	20
4	Public Health	1	1	33
5	Allergy	1	1	26

Giorgio Dini

108

Publications

Citations

H-Index

Page 1

	Year	Citations
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study Katarina Le Blanc, Francesco Frassoni, Lynne M. Ball, The Lancet Regenerative MedicineMesenchymal Stem CellsCell TherapyMedicineStem Cell Transplantation	2008	2.7K
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009 Per Ljungman, Marco Bregni, Mats Brune, Bone Marrow Transplantation TransplantationAutoimmune DiseaseSolid Organ TransplantationEurope 2009Immunology	2009	384
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial Selim Corbacioglu, Simone Cesaro, Maura Faraci, The Lancet TransplantationHepatologyHepatic Veno-occlusive DiseaseStem Cell TransplantationImmunology	2012	372
Risk score for outcome after allogeneic hematopoietic stem cell transplantation Aloïs Gratwohl, Martin Stern, Ronald Brand, Cancer	2009	370
Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients Maria Galotto, Giovanni Berisso, Laura Delfino, Experimental Hematology OncologyMarrow TransplantationTransplantationRadiation TherapyStromal Damage	1999	280
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe Per Ljungman, Álvaro Urbano-Ispizúa, Marina Cavazzana, Bone Marrow Transplantation Transplant RejectionTransplantationAutoimmune DiseaseImmune DisordersSolid Organ Transplantation	2006	266
Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Maria Teresa Van Lint, C Uderzo, Anna Locasciulli, PubMed	1998	225
Extracorporeal photochemotherapy for paediatric patients with graft‐versus‐host disease after haematopoietic stem cell transplantation Chiara Messina, Franco Locatelli, Edoardo Lanino, British Journal of Haematology	2003	190
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group Thomas Klingebiel, Jacqueline Cornish, Myriam Labopin, Blood	2009	181
Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial Franco Locatelli, Marco Zecca, Roberto Rondelli, Blood	2000	166

Page 1